Lidocaine in mDN cardioplegia is a Na+ channel blocker; therefore, it restrains Ca2+ overload through Na+/Ca2+ exchanger and minimizes the potential for a Na+ window current to occur, which leads to a more certain suppression of the myocardial action potential during cardiac arrest. Here, SLC8A1 is linked to cardiac arrest.